SUBLESIONAL BONE LOSS SECONDARY TO SCI

Clinical trials for SUBLESIONAL BONE LOSS SECONDARY TO SCI explained in plain language.

Never miss a new study

Get alerted when new SUBLESIONAL BONE LOSS SECONDARY TO SCI trials appear

Sign up with your email to follow new studies for SUBLESIONAL BONE LOSS SECONDARY TO SCI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug combo aims to rebuild bone in spinal cord injury patients

Disease control Ongoing

This study tests whether a two-step drug treatment can improve bone density in people with long-term spinal cord injury who have bone loss. Participants receive either romosozumab (a bone-building drug) or a placebo for 12 months, followed by denosumab (a bone-strengthening drug)…

Matched conditions: SUBLESIONAL BONE LOSS SECONDARY TO SCI

Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control

Last updated Jun 22, 2026 12:09 UTC

SUBLESIONAL BONE LOSS SECONDARY TO SCI

Get alerted when new SUBLESIONAL BONE LOSS SECONDARY TO SCI trials appear

New drug combo aims to rebuild bone in spinal cord injury patients